The results suggest that the activation of the FXR-SERCA2 pathway can promote eIF2α dephosphorylation in hepatocytes, allowing AT-II to improve NAFLD through modulating the interactions between FXR and ER stress. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.